Skip to main content

APA Annual Meeting

SAN FRANCISCO—Issues such as racial diversity, climate change, and criminal justice will join clinical topics such as ketamine and cannabis on the agenda of this year’s American Psychiatric Association (APA) Annual Meeting.
NEW YORK CITY—A non-narcotic medication currently in clinical development reduced opioid withdrawal symptoms in a pair of phase 3 studies involving more than 800 patients.
NEW YORK CITY—Incoming medical residents are expressing a troubling lack of awareness about diagnosing and treating patients with opioid use disorder, according to research presented at the American Psychiatric Association’s annual meeting.
NEW YORK CITY—The extended-release form of phentermine/topiramate is safe and effective for reducing binge eating, suggests a small study presented at the American Psychiatric Association’s annual meeting.
NEW YORK CITY—Repetitive transcranial magnetic stimulation may help improve refractory depression in patients with borderline personality disorder, says research presented at the American Psychiatric Association’s annual meeting.
Back to Top